can semaglutide raise liver enzymes Cause Damage? Safety Evidence Explained Semaglutide‐Induced Hepatic Injury: A Rare

They can figure out if the symptoms are from the medication or something else

Computational/in silico methods in drug target and lead prediction

5 New Use Cases GLP-1 therapies are also being explored to treat conditions beyond diabetes and obesity

[68] [69] However, a 2025 meta-analytic systematic review of 113 randomized controlled trials found that stimulant medications were the only intervention with robust short-term efficacy, and were associated with lower all-cause treatment discontinuation rates than non-stimulant medications (e.g., atomoxetine)

176 GLP-1RAs and diseases As a rising star in recent years, GLP-1RAs are not only effective in metabolic diseases but also play a role in non-metabolic disorders, affecting multiple systems including the musculoskeletal, nervous, cardiovascular, and digestive systems, and can even have implications in oncological diseases

While there is evidence that growth hormone (GH) secretagogues like ipamorelin can increase lean body mass and decrease fat mass in seniors [11], long-term research shows that elevated GH levels increase disease risks and decrease life expectancy by accelerating the aging process [12]